An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids

NCT00799266 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis

Interventions

DRUG: Zoledronic acid
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals